PatentsThere are six patents (with another pending) owned by CTT that have been licensed by Aurora through CanniMed in Canada. Approval for sale is pending for this summer when the federal regulations are announced. The companies are working together with Health Canada with regards to ensuring this is considered a delivery system and not an edible which would postpone approval for another year. Apparently CTT has multiple offers for the U.S. and international rights as well. A merger or takeover is possible. LDS could very well be one of the interested parties.